Skip to content
Open in App
Labcorp Holdings logo

Labcorp Holdings

web2

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and...

Symbol · N6B
Company profile

About

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Labcorp 2026 Investor Day

KEY STEP

Labcorp announced an Investor Day for September 10, 2026. Chairman and CEO Adam Schechter, CFO Julia Wang and other executive leaders are scheduled to discuss the company's strategy, capital deployment priorities and long term financial outlook.

Roadmap reference
People

Company team

PB

Paul B. Rothman

Independent Director

Company leadership profile.

KB

Kerrii B. Anderson

Independent Director

Company leadership profile.

AH

Adam H. Schechter

President, CEO & Chairman

Company leadership profile.

GA

Garheng Albert Kong

Vice Chairman & Lead Independent Director

Company leadership profile.

RP

Richelle P. Parham

Independent Director

Company leadership profile.

JA

Jeffrey A. Davis

Independent Director

Company leadership profile.

PM

Peter M. Neupert

Independent Director

Company leadership profile.

KE

Kathryn E. Wengel

Independent Director

Company leadership profile.

KM

Kirsten Marie Kliphouse

Independent Director

Company leadership profile.

VB

Victor Bulto

Independent Director

Company leadership profile.

JH

John Howard Sampson

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Labcorp Holdings.

Orbitrum research

Experts evaluating Labcorp Holdings

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment